Search This Blog

Tuesday, August 6, 2019

GW Pharmaceuticals EPS beats by $0.23, beats on revenue

GW Pharmaceuticals (NASDAQ:GWPH): Q2 GAAP EPS of $0.21 beats by $0.23.
Revenue of $72.04M (+2083.0% Y/Y) beats by $26.47M.
Shares +7%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)